Immunological consequences of trauma and shock

Annals of the Academy of Medicine Singapore

Volumn 28, Issue 1, 1999, Pages 120-132

  Catania, R A ^b   Chaudry, Irshad H ^a  

^a RHODE ISLAND HOSPITAL   (United States)

^b NONE

Author keywords

B lymphocytes; Cytokines; Haemorrhage; Macrophages; T lymphocytes

Indexed keywords

B LYMPHOCYTE ACTIVATION; CELL INTERACTION; CYTOKINE RELEASE; HEMORRHAGIC SHOCK; HOST RESISTANCE; HUMAN; IMMUNOSTIMULATION; INFLAMMATORY INFILTRATE; INJURY; LYMPHOCYTIC INFILTRATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0032910226     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. Macho J R, Lewis FR, Krupski W C. Management of the injured patient. In: Way L W, editor. Current Surgical Diagnosis and Treatment. Norwalk, Conn: Appleton&Lange, 1994:213-40.
2. Bone R C. Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 1992; 268:3452-5.
3. Deitch E A. Multiple organ failure: pathophysiology and basic concepts of therapy. New York: Thieme Medical Publishers, Inc, 1990:1-299.
4. Goris R J A. Sepsis and multiple organ failure: The result of whole body inflammation. In: Faist E, Meakins J, Schildberg F W, editors. Host Defense Dysfunction in Trauma, Shock and Sepsis. Berlin-Heidelberg: Springer-Verlag, 1993:161-70.
5. Chaudry I H, Ayala A. Immunological Aspects of Hemorrhage. Austin, TX: Medical Intelligence Unit, RG Landes Co, 1992:1-132.
6. Stephan R N, Ayala A, Chaudry I H. Monocyte and lymphocyte responses following trauma. In: Schlag G, Redl H, editors. Pathophysiology of Shock, Sepsis and Organ Failure. Berlin: Springer-Verlag, 1993:131-44.
7. Baue A E. Multiple organ failure. In: Baue A E, editor. Multiple Organ Failure: Patient Care and Prevention. St Louis, MO: Mosby Year Book, 1990:421-70.
8. Deitch E A. Animal models of sepsis and shock: A review and lessons learned. Shock 1998; 9:1-11.
9. Stephan R N, Kupper T S, Geha A S, Baue A S, Chaudry I H. Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis. Arch Surg 1987; 122:62-8.
10. Abraham E, Freitas A A. Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation. J Immunol 1989; 142:899-906.
11. Saba T M. Reticuloendothelial systemic host defense after surgery and traumatic shock. Circ Shock 1975; 2:91-108.
12. Stephan R N, Mitsuyoski S, Conrad P J, Dean R E, Geha A S, Chaudry I H. Depressed antigen presentation function and membrane interleukin-1 activity of peritoneal macrophages after laparotomy. Surgery 1987; 102:147-54.
13. Mack V E, McCarter M D, Naama H A, Calvano S E, Daly J M. Dominance of T-helper 2-type cytokines after severe injury. Arch Surg 1996; 131:1303-9.
14. Narahara H, Johnston J M. Effects of endotoxins and cytokines on the secretion of platelet-activating factor acetylhydrolase by human decidual macrophages. Am J Obstet Gynecol 1993; 169:531-7.
15. Davies C L, Newman R J, Molyneux S G, Grahame-Smith D G. The relationship between plasma catecholamines and severity of injury in man. J Trauma 1984; 24:99-105.
16. Lydyard P, Grossi C. Cells involved in the immune response. In: Roitt I, Brostoff J, Male D, editors. Immunology. New York: Mosby, 1996:2.1-2.18.
17. Moore E E, Moore F A, Franciose R J, Kim F J, Biffl W L, Banerjee A. The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 1994; 37:881-7.
18. Botha A J, Moore F A, Moore E E, Sauaia A, Banerjee A, Peterson V M. Early neutrophil sequestration after injury: A pathogenic mechanism for multiple organ failure. J Trauma 1995; 39:411-7.
19. Botha A J, Moore F A, Moore E E, Kim F J, Banerjee A, Peterson V M. Postinjury neutrophil priming and activation: An early vulnerable window. Surgery 1995; 118:358-65.
20. Turnage R H, Kadesky K M, Rogers T, Hernandez R, Bartula L, Myers S I. Neutrophil regulation of splanchnic blood flow after hemorrhagic shock. Ann Surg 1995; 222:66-72.
21. Ramamoorthy C, Sharar S R, Harlan J M, Tedder T F, Winn R K. Blocking L-selectin function attenuates reperfusion injury following hemorrhagic shock in rabbits. Am J Physiol 1996; 271:H1871-H1877.
22. Kapoor R, Prasad K. Role of polymorphonuclear leukocytes in cardiovascular depression and cellular injury in hemorrhagic shock and reinfusion. Free Radic Biol Med 1996; 21:609-18.
23. Lawrence M B, Springer T A. Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 1991; 65:859-73.
24. Simms H H, D'Amico R, Burchard K W. Intra-abdominal sepsis: Enhanced auto-oxidative effect on polymorphonuclear leukocyte cell surface receptor expression. Circ Shock 1991; 34:356-65.
25. Simms H H, D'Amico R. Posttraumatic auto-oxidative polymorphonuclear neutrophil receptor injury predicts the development of nosocomial infection. Arch Surg 1997; 132:171-7.
26. Zellweger R, Zhu X, Wichmann M W, Ayala A, DeMaso C M, Chaudry I H. Prolactin administration following hemorrhagic shock improves macrophage cytokine release capacity and decreases mortality from subsequent sepsis. J Immunol 1996; 157:5748-54.
27. Ayala A, Tu Y, Flye M W, Chaudry I H. Depressed splenic function after hemorrhage results from gastrointestinal tract stimulation of hepatic-mediator release. Correction with portacaval shunt. Arch Surg 1996; 131:1209-14.
28. Wichmann M W, Zellweger R, DeMaso C M, Ayala A, Chaudry I H. Melatonin administration attenuates depressed immune functions after trauma-hemorrhage. J Surg Res 1996; 63:256-62.
29. Nwariaku F E, McIntyre K I, Sikes P J, Mileski W J. Alterations in alveolar macrophage tumor necrosis factor (TNF) response following hemorrhagic shock. Shock 1995; 4:200-3.
30. Chaudry I H, Zellweger R, Ayala A. The role of bacterial translocation on Kupffer cell immune function following hemorrhage. In: Levin J, Alving C R, Munford R S, Redl H, editors. Progress in Clinical and Biological Research. Vol 392. Bacterial Endotoxins-Lipopolysaccharides from Genes to Therapy. New York: Wiley-Liss, 1995:209-18.
31. Zellweger R, Ayala A, DeMaso C M, Chaudry I H. Trauma-hemorrhage causes prolonged depression in cellular immunity. Shock 1995; 4:149-53.
32. Hauser C J, Lagoo S, Lagoo A, Hale E, Hardy K J, Barber W H, et al. Tumor necrosis factor alpha gene expression in human peritoneal macrophages is suppressed by extra-abdominal trauma. Arch Surg 1995; 130:1186-91.
33. Kelly C J, Gallagher H, Wolf B A, Daly J M. Alterations in macrophage signal transduction pathways mediate post-traumatic changes in macrophage function. J Surg Res 1994; 57:221-6.
34. Ayala A, Perrin M M, Wagner M A, Chaudry I H. Enhanced susceptibility to sepsis following simple hemorrhage: Depression of Fc and C3b receptor mediated phagocytosis. Arch Surg 1990; 125:70-5.
35. Rana M W, Ayala A, Dean R E, Chaudry I H. Decreased Fc receptor expression on macrophages following simple hemorrhage as observed by scanning immuno electron microscopy. J Leukocyte Biol 1990; 48:512-8.
36. Ertel W, Meldrum D R, Morrison M H, Ayala A, Chaudry I H. Immunoprotective effect of a calcium channel blocker on macrophage antigen presentation function, major histocompatibility class II antigen expression and interleukin-1 synthesis after hemorrhage. Surgery 1990; 108:154-60.
37. Ayala A, Perrin M M, Chaudry I H. Defective macrophage antigen presentation following haemorrhage is associated with the loss of MHC class II (Ia) antigens. Immunology 1990; 70:33-9.
38. Ertel W, Morrison M H, Ayala A, Chaudry I H. Modulation of macrophage membrane phospholipids by n-3 polyunsaturated fatty acids increases interleukin-1 release and prevents suppression of cellular immunity following hemorrhagic shock. Arch Surg 1993; 128:15-21.
39. Ertel W, Morrison M H, Ayala A, Chaudry I H. Chloroquine attenuates hemorrhagic shock-induced immunosuppression and decreases susceptibility to sepsis. Arch Surg 1992;127:70-6.
40. Ertel W, Morrison M H, Ayala A, Chaudry I H. Insights into the mechanisms of defective antigen presentation following hemorrhage. Surgery 1991; 110:440-7.
41. Ayala A, Perrin M M, Wang P, Ertel W, Chaudry I H. Hemorrhage induces enhanced Kupffer cell cytotoxicity while decreasing peritoneal or splenic macrophage capacity: involvement of cell-associated TNF and reactive nitrogen. J Immunol 1991; 147:4147-54.
42. Mayberry A, Ayala A, Chaudry I H. Hemorrhage affects the ability of murine peritoneal macrophages to alkanize intracellular pH in acidic environments. J Surg Res 1995; 58:682-6.
43. Ertel W, Morrison M H, Ayala A, Chaudry I H. Eicosanoids regulate tumor necrosis factor synthesis following hemorrhage in vitro and in vivo. J Trauma 1991; 31:609-16.
44. Ertel W, Morrison M H, Ayala A, Perrin M M, Chaudry I H. Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage functions following hemorrhagic shock. Ann Surg 1991; 213:265-71.
45. Walker C, Kristensen F, Bettens F, DeWeck A L. Lymphokine regulation of activated (G1) lymphocytes: prostaglandin E2-induced inhibition of interileukin 2 production. J Immunol 1983; 130:1770-3.
46. Knapp W, Baumgartner G. Monocyte-mediated suppression of human B lymphocyte differentiation in vitro. J Immunol 1978; 121:1177-83.
47. Faist E, Mewes A, Baker C C, Strasser T, Alkan S S, Rieber P, et al. Prostaglandin E2 dependent suppression of interleukin-2 production in patients with major trauma. J Trauma 1987; 27:837-48.
48. Shenkar R, Coulson W F, Abraham E. Anti-transforming growth factor-beta monoclonal antibodies prevent lung injury in hemorrhaged mice. Am J Resp Cell Mol Biol 1994; 11:351-7.
49. Zellweger R, Ayala A, Zhu X, Holme K R, DeMaso C M, Chaudry I H. A novel nonanticoagulant heparin improves splenocytc and peritoneal macrophage immune function after trauma-hemorrhage and resuscitation. J Surg Res 1995; 59:211-8.
50. Zingarelli B, Squadrito F, Altavilla D, Calapai G, DiRosa M, Caputi A P. Role of tumor necrosis factor-alpha in acute hypovolemic hemorrhagic shock in rats. Am J Physiol 1994; 266:H1512-H1515.
51. Zhu X, Zellwegcr R, Zhu X, Ayala A, Chaudry I H. Cytokine gene expression in splenic macrophages and Kupffer cells following haemorrhage. Cytokine 1995; 7:8-14.
52. Zhu X, Ayala A, Zellweger R, Morrison M H, Chaudry I H. Peritoneal macrophages show increased cytokine gene expression following hemorrhagic shock. Immunology 1994; 83:378-83.
53. Shenkar R, Coulson W F, Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Resp Cell Mol Biol 1994; 10:290-7.
54. Shenkar R, Abraham E. Effects of hemorrhage on cytokine gene transcription. Lymphokine Cytokine Res 1993; 12:237-47.
55. 2 administration normalizes macrophage cyclic AMP and b-adrenergic receptors after hemorrhage and resuscitation. Am J Physiol 1994; 267:G52-G58.
56. Ayala A, Wang P, Chaudry I H. Insights into the mechanism by which interferon-gamma improves macrophage function following hemorrhage and resuscitation. J Surg Res 1993; 54:322-7.
57. Ayala A, Chaudry I H. Hemorrhage induces a reduction in the capacity of macrophages to mobilize intracellular calcium secondary to formyl-methionyl-leucyl-phenylalanine stimulation: Association with alterations in cell surface Fc receptor expression and increased prostaglandin release. Shock 1994; 1:228-35.
58. 2. Surgery 1992; 112:150-8.
59. Ertel W, Morrison M H, Ayala A, Chaudry I H. Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release. Am J Physiol 1995; 269:R160-R166.
60. Renk C M, Long C L, Blakemore W S. Comparison between in vitro lymphocyte activity and metabolic changes in trauma patients. J Trauma 1982; 22:134-40.
61. Levy E M, Alharbi S A, Grindlinger G, Black P H. Changes in mitogen responsiveness lymphocyte subsets after traumatic injury: Relation to development of sepsis. Clin Immunol Immunopathol 1984; 32:224-33.
62. O'Mahony J B, Palder Sb, Wood J J, Mclrvine A, Rodrick M L, Demling R H, et al. Depression of cellular immunity after multiple trauma in the absence of sepsis. J Trauma 1984; 24:869-75.
63. Abraham E, Lee R J, Chang Y. The role of interleukin 2 in hemorrhage-induced abnormalities of lymphocyteproliferation.Circ Shock 1986; 18:205-13.
64. Schmand J F, Ayala A, Chaudry I H. Effects of trauma, duration of hypotension, and resuscitation regimen on cellular immunity following hemorrhagic shock. Crit Care Med 1994; 22:1076-83.
65. Schmand J F, Ayala A, Morrison M H, Chaudry I H. Dextran 70 administration after trauma-hemorrhagic shock does not impair cellular immune functions. J Crit Care 1994; 9:244-54.
66. Zellweger R, Ayala A, Schmand J F, Morrison M H, Chaudry I H. PAF-antagonist administration after hemorrhage-resuscitation prevents splenocyte immunodepression. J Surg Res 1995; 59:366-70.
67. Schmand J F, Ayala A, Morrison M H, Chaudry IH. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: Restoration of macrophage integrity and prevention of increased circulating interleukin-6 levels. Crit Care Med 1995; 25:806-14.
68. Zellweger R, Wichmann M W, Ayala A, DeMaso C M, Chaudry I H. Prolactin: a novel and safe immunomodulating hormone for the treatment of immunodepression following severe hemorrhage. J Surg Res 1996; 63:53-8.
69. Xu Y X, Ayala A, Chaudry I H. Prolonged immunodepression after trauma and hemorrhagic shock. J Trauma 1998 (In press).
70. Wichmann M W, Zellweger R, Williams C, Ayala A, DeMaso C M, Chaudry I H. Immune function is more compromised following closed bone fracture and hemorrhagic shock than hemorrhage alone. Arch Surg 1996; 131:995-1000.
71. Wichmann M W, Arnoczky S P, DeMaso C M, Ayala A, Chaudry IH. Depressed osteoblast activity and increased osteocyte necrosis following closed bone fracture and hemorrhagic shock. J Trauma 1996; 41:628-33.
72. Ertel W, Faist E, Nestle C, Hueltner L, Storck M, Schildberg F W. Kinetics of interleukin-2 and interleukin-6 synthesis following major mechanical trauma. J Surg Res 1990; 48:622-8.
73. Miller-Graziano C L, De A K, Kodys K. Altered IL-10 levels in trauma patients' M phi and T lymphcytes. J Clin Immunol 1995; 15:93-104.
74. De A K, Kodys K, Puyana J C, Fudem G, Pellegrini J, Miller-Graziano C L. Only a subset of trauma patients with depressed mitogen responses have true T cell dysfunctions. Clin Immunol Immunopathol 1997; 82:73-82.
75. OSullivan S T, Lederer J A, Horgan A F, Chin D H L, Mannick J A, Rodrick M L. Major injury leads to predominance of the T helper-2 lymphocyte phenotype and diminished interleukin-12 production associated with decreased resistance to infection. Ann Surg 1995; 222:482-92.
76. Abraham E, Chang Y. Haemorrhage-induced alterations in function and cytokine productio of T cells and T cell subpopulations. Clin Exp Immunol 1992; 90:497-502.
77. Abraham E, Freitas A A. Hemorrhage in mice induces alterations in immunoglobulin-secretingB-cells. Crit Care Med 1989; 17:1015-9.
78. Dawson C W, Ledgerwood A M, Rosenberg J C, Lucas C E. Anergy and altered lymphocyte function in the injured patient. Am Surg 1982; 48:397-401.
79. Robinson A, Abraham E. Effects of haemorrhage on bacterial antigen specific pulmonary plasma cell function. Clin Exp Immunol 1992; 88:124-8.
80. Robinson A, Abraham E. Hemorrhage in mice produces alterations in pulmonary B cell repertoires. J Immunol 1990; 145:3734-9.
81. Abraham E, Chang Y-H. Hemorrhage in mice produces alterations in intestinal B cell repertoires. Cell Immunol 1990; 128:165-74.
82. Richter M, Jodouin C A, Moher D, Barron P. Immunologic defects following trauma: A delay in immunoglobulin synthesis by cultured B cells following traumatic accidents but not elective surgery. J Trauma 1990; 30:590-6.
83. Teodorczyk-Injeyan J A, Cembrzynska-Nowak M, Lalani S, Rizoli S, Taylor G. Tumor necrosis factor alpha regulation of immunoglobulin secretion in trauma patients. Circ Shock 1994; 43:26-33.
84. Abraham E, Freitas A A, Coutinho A A. Hemorrhage in mice produces alterations in B-cell repertoires. Cell Immunol 1989; 122:208-17.
85. Kong L B, Lekawa M, Navarro R A, McGrath J, Cohen M, Margulies D R, et al. Pedestrian-motor vehicle trauma: An analysis of injury profiles by age. JACS 1996; 182:17-23.
86. Feero S, Hedges J R, Simmons E, Irwin L. Intracity regional demographics of major trauma. Ann Emerg Med 1995; 25:788-93.
87. Williams J M, Furbee P M, Prescott J E, Paulson D J. The emergency department log as a simple injury-surveillance tool. Ann Emerg Med 1995; 25:686-91.
88. Poole G V, Griswold J A, Thaggard V K, Rhodes R S. Trauma is a recurrent disease. Surgery 1993; 113:608-11.
89. Garibaldi R A, Britt M R, Coleman M L, Reading J C, Pace N L. Risk factors for postoperative pneumonia. Am J Med 1981; 70:677-80.
90. Malone D A, Wagner R A, Myers J P, Watanakunakorn C. Enterococcal bacteremia in two large community teaching hospitals. Am J Med 1986; 81:601-6.
91. Salive M E, Wallace R B, Ostfeld A M, Satterfield S, Havlik R J. Risk factors for septicemia-assodated mortality in older adults. Public Health Rep 1993; 108:447-53.
92. Wichmann M W, Zellweger R, DeMaso C M, Ayala A, Chaudry I H. Enhanced immune responses in females as opposed to decreased responses in males following hemorrhagic shock. Cytokine 1996; 8:853-63.
93. Zellweger R, Wichmann M W, Ayala A, Stein S, DeMaso C M, Chaudry I H. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 1997; 25:106-10.
94. Wichmann M W, Zellweger R, DeMaso C M, Ayala A, Chaudry I H. Mechanisms of immunosuppression in males following trauma-hemorrhage: Critical role of testosterone. Arch Surg 1996; 131:1186-92.
95. Wichmann M W, Ayala A, Chaudry I H. Male sex steroids are responsible for depressing macrophage immune function after traumahemorrhage. Am J Physiol 1997; 273:C1335-C1340.
96. Angele M K, Ayala A, Cioffi W G, Bland K I, Chaudry I H. Testosterone: The culprit for producing splenocyte immune depression following traumahemorrhage. Am J Physiol 1998 (In press).
97. Angele M K, Ayala A, Monfils B A, Cioffi W G, Bland K I, Chaudry I H. Testosterone and/or low estradiol: Normally required but harmful immunologically for males after trauma-hemorrhage. J Trauma 1998; 44:78-85.
98. Wichmann M W, Angele M K, Ayala A, Cioffi W G, Chaudry I H. Flutamide: A novel agent for restoring the depressed cell-mediatd immunity following soft-tissue trauma and hemorrhagic shock. Shock 1997; 8:242-8.
99. Angele M K, Wichmann M W, Ayala A, Cioffi W G, Chaudry I H. Testosterone receptor blockade after hemorrhage in males: Restoration of the depressed immune functions and improved survival following subsequent sepsis. Arch Surg 1997; 132:1207-14.
100. Viselli S M, Olsen N J, Shults K, Steizer G, Kovacs W J. Immunochemical and flow cytometric analysis of androgen receptor expression in thymocytes. Mol Cell Endocrinol 1995; 109:19-26.
101. Cutolo M, Sulli A, Seriolo B, Accardo S, Masi A T. Estrogens, the immune response and autoimmunity. Clin Exp Rheum 1995; 13:217-26.
102. Slater C H, Fitzpatrick T M, Schreck C B. Characterization of an androgen receptor in salmonid lymphocytes: Possible link to androgen-induced immunosuppression. Gen Comp Endocrinol 1995; 100:218-25.
103. Cutolo M, Accardo S, Villaggio B, Barone A, Sulli A, Coviello D A, et al. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996; 81:820-7.
104. Remmers D E, Cioffi W G, Bland K I, Wang P, Angele M K, Chaudry I H. Testosterone: The crucial hormone responsible for depressing myocardial function in males after trauma-hemorrhage. Ann Surg 1998 (In press).
105. Baron R L. Pathophysiology of septic shock and implications for therapy. Clin Pharmacol Ther 1993; 12:829-45.
106. Chaudry I H. Cellular mechanisms in shock and ischemia and their correction. Am J Physiol 1983; 245:R117-R134.
107. Harkema J M, Chaudry I H. Magnesium-ATP in the treatment of shock, ischemia and sepsis. Crit Care Med 1992; 20:263-75.
108. Meldrum D R, Ayala A, Wang P, Ertel W, Chaudry I H. Association between decreased splenic ATP levels and immunodepression: amelioration with ATP-MgC12. Am J Physiol 1991; 261:R351-R357.
109. 2 improves energetics and decreases lethality. J Surg Res 1994; 56:537-42.
110. Rana M W, Singh G, Wang P, Ayala A, Zhou M, Chaudry I H. Protective effects of preheparinization on the microvasculature during and after hemorrhagic shock. J Trauma 1992; 32:420-6.
111. Wang P, Ba Z F, Reich S S, Zhou M, Holme K R, Chaudry I H. Effects of nonanticoagulant heparin on cardiovascular and hepatocellular function after hemorrhagic shock. Am J Physiol 1996; 270:H1294-H1302.
112. Freedman A. Chloroquine and rheumatoid arthritis: short term controlled trial. Ann Rheum Dis 1956; 15:251-7.
113. Authi K S, Tragnor J R. Effects of anti-malarial drugs on phospholipase A2. Br J Pharmacol 1979; 66:496-501.
114. Ertel W, Morrison M H, Ayala A, Chaudry I H. Chloroquine attenuates hemorrhagic shock induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression through blockade of tumor necrosis factor and prostaglandin release. Blood 1991; 78:1781-8.
115. Zhu X, Ertel W, Ayala A, Morrison M H, Perrin M M, Chaudry I H. Chloroquine inhibits macrophage tumour necrosis factor-a mRNA transcription. Immunology 1993; 80:122-6.
116. Karres I, Kremer J, Dietl I, Steckholzer U, Jochum M, Ertel W. Chloroquine inhibits proinflammatory cytokine release into human whole blood. Am J Physiol 1998; 274:R1058-R1064.
117. Choudhry M A, Ahmad S, Thompson K D, Sayeed M M. Erratum: T-lymphocyte Ca2+ signalling and proliferative responses during sepsis. Shock 1994; 1:466-71.
118. Hess M L, Warner M F, Smith J M, Manson N H, Greenfield L J. Improved myocardial hemodynamic and cellular function with calcium channel blockade (verapamil) during canine hemorrhagic shock. Circ Shock 1983; 10:119-30.
119. Westfall M V, Sayeed M M. Effect of diltiazem on skeletal muscle 3-0-methylglucose transport in bacteremic rats. Am J Physiol 1989; 256:R716-R721.
120. Meldrum D R, Ayala A, Chaudry I H. Mechanism of diltiazem's immunomodulatory effects after hemorrhage and resuscitation. Am J Physiol 1993; 265:C412-C421.
121. Meldrum D R, Ayala A, Perrin M M, Ertel W, Chaudry I H. Diltiazem restores IL-2, IL-3, IL-6 and IFN-gamma synthesis and decreases susceptibility to sepsis following hemorrhage. J Surg Res 1991; 51:158-64.
122. 2 production in severely injured patients. Arch Surg 1988; 123:293-9.
123. Ertel W, Morrison M H, Meldrum D R, Ayala A, Chaudry I H. Ibuprofen restores cellular immunity and decreases susceptibility to sepsis following hemorrhage. J Surg Res 1992; 53:55-61.
124. Schow S R, JoIy A. N-acetyl-leucinyl-leucinyl-norleucinal inhibits lipopolysaccharide-induced NF-kappaB activation and prevents TNF and IE-6 synthesis in vivo. Cell Immunol 1997; 175:199-202.
125. Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/ tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985; 229:869-71.
126. Tracey K J, Fong Y, Hesse D G, Manogue K R, Lee A T, Kuo G C, et al. Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature 1987; 330:662-4.
127. Mullen P, Windsor A, Walsh C, et al. Effect of monoclonal antibody to tumor necrosis factor-a on neutrophil oxidant generation [abstract]. Circ Shock 1992; 37:21.
128. Pellicane J V, DeMaria E J, Leeper-Wood ford S, Lee R B, Fowler A A. Tumor necrosis factor antibody improves survival following hemorrhagic shock in awake rats [abstract]. Circ Shock 1992; 37:54.
129. Ertel W, Morrison M H, Ayala A, Perrin M M, Chaudry I H. Anti-TNF monoclonal antibodies prevent haemorrhage induced suppression of Kupffer cell antigen presentation and MHC class II antigen expression. Immunology 1991; 74:290-7.
130. Ertel W, Morrison M H, Ayala A, Chaudry I H. Biological significance of elevated TNF levels: In vivo administration of monoclonal antibody against TNF following haemorrhagic shock increases the capacity of macrophages to release TNF while restoring immunoresponsiveness. Cytokine 1994; 6:624-32.
131. Abraham E, Wunderink R, Silverman H, Perl T M, Nasraway S, Levy H, et al. Efficacy and safety of monoclonl antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: A randomized, controlled, double-blind, multicenter clinical trial. JAMA 1995; 273:934-41.
132. Cohen J, Carlet J. INTERSEPT: An international, multicenter, placebo-controlled trial of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis. Crit Care Med 1996; 24:1431-40.
133. Villa P, Sartor G, Angelini M, Sironi M, Conni M, Gnocchi P, et al. Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol 1995; 2:549-53.
134. Strieter R M, Remick D G, Ward P A, Spengler R N, Lynch J P I, Larrick J, et al. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Comm 1988; 155:1230-6.
135. Wang P, Ba Z F, Zhou M, Chaudry I H. Pentoxifylline restores cardiac output and tissue perfusion following trauma-hemorrhage and decreases susceptibility to sepsis. Surgery 1993; 114:352-9.
136. Mandi Y, Farkas G, Ocsovszky I, Nagy Z. Inhibition of tumor necrosis factor production and ICAM-1 expression by pentoxifylline: Beneficial effects in sepsis syndrome. Res Exp Med 1995; 195:297-307.
137. Lundblad R, Ekstrom P, Giercksky K E. Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Shock 1995; 3:210-5.
138. Doherty G M, Jensen C, Alexander H R, Buresh C M, Norton J A. Pentoxifylline suppression of tumor necrosis factor gene transcription. Surgery 1991; 110:192-8.
139. Man J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990; 172:391-4.
140. Endres S, Fulle H J, Sinha B, Stoll D, Dinarello C A, Gerzer R, et al. Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor- alpha and interleukin-1 beta by human mononuclear cells. Immunology 1991; 72:56-60.
141. Bernton E W. Prolactin and immune host defenses. Prog Neuroendocrine Immunol 1989; 2:21-9.
142. Walker S E. Prolactin: an immune-stimulating peptide that regulates other immune-modulating hormones [editorial]. Lupus 1993; 2:67-9.
143. Zhu X, Zellweger R, Ayala A, Chaudry I H. Prolactin inhibits the increased cytokine gene expression in Kupffer cells following haemorrhage. Cytokine 1996; 8:134-40.
144. Ehrenkranz R A, Ackerman B A. Metoclopramide effect on faltering milk production by mothers of premature infants. Pediatrics 1986; 78:614-20.
145. Zellweger R, Wichmann M W, Ayala A, Chaudry I H. Metoclopramide: A novel and safe immunomodulating agent for restoring the depressed macrophage immune function after hemorrhage. J Trauma 1998; 41:1-8.
146. Catania R A, Angele M K, Ayala A, Cioffi W G, Bland K I, Chaudry I H. Dehydroepiandrosterone (DHEA): A novel steroid hormone therapy for restoring T-lymphocyte function following trauma and hemorrhage. Surg Forum 1998 (In press).
147. Angele M K, Knoferl M W, Ayala A, Cioffi W G, Bland K I, Chaudry I H. Male and female sex steroids: Do they produce deleterious or beneficial effects on immune responses following trauma-hemorrhage? Surg Forum 1998 (In press).